Neil B Kavey
Medical Practice in Chappaqua, NY
License number
New Jersey 25MA02601700
Expiration Date
Jun 30, 1997
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Chappaqua, NY
Organization information
See more information about Neil B Kavey at bizstanding.comNEIL B. KAVEY, M.D., PC
26 W Orch Dr, Chappaqua, NY 10514
Registration:
Jul 20, 1993
State ID:
1742727
Business type:
DOMESTIC PROFESSIONAL CORPORATION
Neil B Kavey Md, 26 W Orch Dr, Chappaqua, NY 10514 (Physical)
Agent:
C/O Neil B. Kavey, M.d,26 W Orch Rd, Chappaqua, NY 10514 (Physical)
Professional information
Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
US Patent:
2013015, Jun 13, 2013
Filed:
Feb 11, 2013
Appl. No.:
13/764467
Inventors:
Roberta L. Rogowski - Rancho Santa Fe CA, US
Neil B. Kavey - Chappaqua NY, US
Neil B. Kavey - Chappaqua NY, US
Assignee:
SOMAXON PHARMACEUTICALS, INC. - Solana Beach CA
International Classification:
A61K 31/335
US Classification:
514450
Abstract:
Methods of treating sleep disorders by administration of low doses of doxepin in individuals seeking sustained efficacy or in need of avoiding weight gain, rebound insomnia, or sedative tolerance resulting from doxepin treatment.
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
US Patent:
2010017, Jul 15, 2010
Filed:
Aug 4, 2009
Appl. No.:
12/535623
Inventors:
Susan E. Dubé - Carlsbad CA, US
Neil B. Kavey - Chappaqua NY, US
Neil B. Kavey - Chappaqua NY, US
Assignee:
SOMAXON PHARMACEUTICALS, INC. - San Diego CA
International Classification:
A61K 31/335, A61P 25/20
US Classification:
514450
Abstract:
The invention relates to use of the trans-(E) isomer or isomeric mixtures containing specified ratios of the trans-(E) and cis-(Z) isomers of doxepin, metabolites of doxepin, pharmaceutically-acceptable salts of doxepin and prodrugs of the same; compositions containing the same, for the treatment of sleep disorders
Low-Dose Doxepin For Treatment Of Sleep Disorders In Elderly Patients
US Patent:
2013001, Jan 17, 2013
Filed:
Sep 17, 2012
Appl. No.:
13/621665
Inventors:
PROCOM ONE, INC. - San Marcos TX, US
Philip Jochelson - San Diego CA, US
Neil Barton Kavey - Chappaqua NY, US
Philip Jochelson - San Diego CA, US
Neil Barton Kavey - Chappaqua NY, US
Assignee:
PROCOM ONE, INC. - San Marcos TX
SOMAXON PHARMACEUTICALS, INC. - Solana Beach CA
SOMAXON PHARMACEUTICALS, INC. - Solana Beach CA
International Classification:
A61K 31/335, A61P 25/20, A61P 25/00
US Classification:
514450
Abstract:
Methods of treating sleep disorders, particularly certain aspects of insomnia, in elderly patients (65 years and older) by administering initial daily dosages of doxepin of 1-3 mg. These ultra-low initial dosages are more effective in elderly versus non-elderly patients in decreasing wake time during sleep, latency to persistent sleep and wake time after sleep, and are particularly efficacious in treating those conditions in the last hour of an 8-hour sleep cycle. Also, the dosages described herein are safe for elderly individuals.
Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
US Patent:
2010017, Jul 15, 2010
Filed:
Aug 4, 2009
Appl. No.:
12/535640
Inventors:
Neil B. Kavey - Chappaqua NY, US
Assignee:
SOMAXON PHARMACEUTICALS, INC. - San Diego CA
International Classification:
A61K 31/335, A61P 25/20
US Classification:
514450
Abstract:
The invention relates to use of the cis-(Z) isomer or isomeric mixtures containing specified ratios of the cis-(Z) and trans-(E) isomers of doxepin, metabolites of doxepin, pharmaceutically-acceptable salts of doxepin and prodrugs of the same; compositions containing the same, for the treatment of sleep disorders
Combination Therapy Using Low-Dose Doxepin For The Improvement Of Sleep
US Patent:
2013000, Jan 3, 2013
Filed:
Sep 12, 2012
Appl. No.:
13/612328
Inventors:
Philip Jochelson - San Diego CA, US
Robert Mansbach - San Diego CA, US
Michael Skinner - San Diego CA, US
Neil B. Kavey - Chappaqua NY, US
Robert Mansbach - San Diego CA, US
Michael Skinner - San Diego CA, US
Neil B. Kavey - Chappaqua NY, US
Assignee:
Somaxon Pharmaceuticals, Inc. - Solana Beach CA
International Classification:
A61K 31/335, A61K 31/5513, A61K 31/519, A61K 31/4985, A61K 31/437, A61K 31/4535, A61K 31/517, A61K 31/496, A61K 31/404, A61K 31/53, A61K 31/428, A61K 31/4433, A61K 31/506, A61K 38/22, A61P 25/00, A61K 31/5517
US Classification:
514 97, 514450, 514220, 514221, 5142593, 514249, 514300, 514302, 514326, 51426622, 51425941, 51425409, 514419, 514242, 5142592, 51425405, 51425304, 514372, 514337, 51425215
Abstract:
A composition comprising doxepin, or a pharmaceutically acceptable salt, or prodrug thereof, and a compound that enhances sleep onset, sleep maintenance or reduces early morning awakenings. These compositions are useful for treating multiple manifestations of insomnia.
N-Desmethyl-Doxepin And Methods Of Using The Same To Treat Sleep Disorders
US Patent:
2010022, Sep 9, 2010
Filed:
May 18, 2007
Appl. No.:
12/301457
Inventors:
Neil B. Kavey - Chappaqua NY, US
Susan E. Dube - Carlsbad CA, US
Susan E. Dube - Carlsbad CA, US
Assignee:
SOMAXON PHARMACEUTICALS, INC - SAN DIEGO CA
International Classification:
A61K 31/335, C07D 313/12, A61P 25/00
US Classification:
514450, 549354
Abstract:
The invention relates to desmethyldoxepin, isomers of desmethyldoxepin, and pharmaceutically acceptable salts and prodrugs of desmethyldoxepin; compositions containing the same, and the use of any of the aforementioned for the treatment of sleep disorders.
Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
US Patent:
2012024, Sep 27, 2012
Filed:
Jun 8, 2012
Appl. No.:
13/492559
Inventors:
Roberta L. Rogowski - Rancho Santa Fe CA, US
Susan E. Dubé - Carlsbad CA, US
Philip Jochelson - San Diego CA, US
Neil B. Kavey - Chappaqua NY, US
Susan E. Dubé - Carlsbad CA, US
Philip Jochelson - San Diego CA, US
Neil B. Kavey - Chappaqua NY, US
Assignee:
SOMAXON PHARMACEUTICALS, INC. - San Diego CA
International Classification:
A61K 31/335, A61P 25/00
US Classification:
514450
Abstract:
Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
US Patent:
2011017, Jul 21, 2011
Filed:
Dec 22, 2010
Appl. No.:
12/976866
Inventors:
Roberta L. Rogowski - Rancho Sante Fe CA, US
Susan E. Dube - Crlsbad CA, US
Philip Jochelson - San Diego CA, US
Neil B. Kavey - Chappaqua NY, US
Susan E. Dube - Crlsbad CA, US
Philip Jochelson - San Diego CA, US
Neil B. Kavey - Chappaqua NY, US
Assignee:
SOMAXON PHARMACEUTICALS, INC. - San Diego CA
International Classification:
A61K 31/335, A61P 25/00
US Classification:
514450
Abstract:
Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).
Low Dose Doxepin Formulations, Including Buccal, Sublingual And Fastmelt Formulations, And Uses Of The Same To Treat Insomnia
US Patent:
2011031, Dec 29, 2011
Filed:
May 18, 2007
Appl. No.:
12/301223
Inventors:
Luigi Schioppi - Escondido CA, US
Brian T. Dorsey - Encinitas CA, US
Michael Skinner - San Diego CA, US
John Carter - Keswick, CA
Terry Cobb - Steamboat Springs CO, US
Neil B. Kavey - Chappaqua NY, US
Brian T. Dorsey - Encinitas CA, US
Michael Skinner - San Diego CA, US
John Carter - Keswick, CA
Terry Cobb - Steamboat Springs CO, US
Neil B. Kavey - Chappaqua NY, US
Assignee:
Somaxon Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/335, C07D 313/10, A61K 9/28, A61K 9/68, A61P 25/20, A61K 9/00
US Classification:
424465, 514450, 424400, 424 48, 549354, 424 43
Abstract:
The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
Treatment For Insomnia
US Patent:
5643897, Jul 1, 1997
Filed:
Mar 25, 1996
Appl. No.:
8/623892
Inventors:
Neil B. Kavey - Chappaqua NY
International Classification:
A61K 3133, A61K 31555, A61K 31335, A61K 3140
US Classification:
514183
Abstract:
A method for the treatment of chronic insomnia is disclosed which involves the administration of low dosages of a compound selected from the pharmaceutically acceptable forms of doxepin, trimipramine, amitriptyline, trazodone and mixtures hereof.